探索PET in vivo生成器134Ce作为对225AcAc的治疗学匹配

David Bauer1, Roberto De Gregorio1, Edwin C Pratt1

  • 1Department of Radiology and the Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

概括

放射性核素对-134/兰坦-134 (134Ce/134La) 显示出作为动素-225 (225Ac) 的热解合作伙伴的希望,但由于134La的再分配,对定量PET成像有局限性.